Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
01 2BAYER HLTHCARE
02 2MYLAN SPECIALITY LP
03 2VIATRIS
01 48071073
02 18168620
03 18168620*PED
01 6Blank
01 5Y
02 1Blank
01 12026-02-24
02 12026-08-24
03 42028-06-04
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2028-06-04
US Patent Number : 8071073
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 213872
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-04
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2028-06-04
US Patent Number : 8071073
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 213872
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-04
Patent Expiration Date : 2026-02-24
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
US Patent Number : 8168620
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202236
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-02-24
Patent Expiration Date : 2028-06-04
US Patent Number : 8071073
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22203
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-04
Patent Expiration Date : 2028-06-04
US Patent Number : 8071073
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22203
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-04
Patent Expiration Date : 2026-08-24
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
US Patent Number : 8168620*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 202236
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-08-24
